Guangdong Jiaying Pharmaceutical Co., Ltd (SHE:002198)

Market Cap	1.48B -56.6%
Revenue (ttm)	385.04M -4.5%
Net Income	27.53M -10.7%
EPS	0.05 -15.9%
Shares Out	497.11M
PE Ratio	58.10
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,980,900
Open	3.360
Previous Close	2.970
Day's Range	2.950 - 3.360
52-Week Range	2.900 - 8.430
Beta	-0.02
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About SHE:002198

Guangdong Jiaying Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese patent medicines in Mainland China. The company offers medicines primarily for the treatment of throat ailments, colds, orthopedics, rheumatism, gynecology, hepatobiliary diseases, tonics, and gastrointestinal disorders. It also provides Shuangliao Houfeng powder, Chongganling tablets, Jiegu Qili tablets (capsules), Xiaoyan Lidan Tablets, and Jinju Wuhua tea, etc., as well as double throat lozenges and tablets, heavy psychotherapy...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 2003
• Employees: 594
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002198

Financial Performance

In 2025, SHE:002198's revenue was 383.75 million, an increase of 2.02% compared to the previous year's 376.17 million. Earnings were 30.48 million, an increase of 47.87%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jul 22, 2026

Data Sources Report a data error